Kalvista PharmaceuticalsKALV
13F holders, Q2 2026 (June 30)1holders −183
1new positions
180sold out
$27.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Kalvista Pharmaceuticals Inc. (KALV) in their 13F filings, down 183 from Q1 2026. 1 opened new positions and 180 sold out. The largest holder was IFP Advisors, Inc ($189).
- Company
- Kalvista Pharmaceuticals Inc.
- CUSIP
- 483497103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $189 |
| Exits | 180 | $1.4B |
All 13F filers, Q1 2026 → Q2 2026: 7 shares bought and 69,208,334 shares sold, net −69,208,327 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | New | 7 | $189 |
"% of holder's portfolio" is KALV's weight in each manager's 13F, not the share of Kalvista Pharmaceuticals Inc. the manager owns.